These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17206427)

  • 1. Characterization of myocardial viability using MR and CT imaging.
    Krombach GA; Niendorf T; Günther RW; Mahnken AH
    Eur Radiol; 2007 Jun; 17(6):1433-44. PubMed ID: 17206427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of delayed myocardial enhancement and value of MR and CT contrast materials in the evaluation of myocardial viability].
    Jacquier A; Revel D; Croisille P; Gaubert JY; Saeed M
    J Radiol; 2010; 91(7-8):751-7. PubMed ID: 20814358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed contrast-enhanced MRI: use in myocardial viability assessment and other cardiac pathology.
    Bogaert J; Dymarkowski S
    Eur Radiol; 2005 Feb; 15 Suppl 2():B52-8. PubMed ID: 15801058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT of coronary heart disease: Part 1, CT of myocardial infarction, ischemia, and viability.
    Vliegenthart R; Henzler T; Moscariello A; Ruzsics B; Bastarrika G; Oudkerk M; Schoepf UJ
    AJR Am J Roentgenol; 2012 Mar; 198(3):531-47. PubMed ID: 22357992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel imaging in cardiovascular MRI: methods and applications.
    Niendorf T; Sodickson DK
    NMR Biomed; 2006 May; 19(3):325-41. PubMed ID: 16705633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnetic resonance tomography in myocardial ischemia: state of the art].
    Szolar DH; Saeed M; Higgins CB
    Rofo; 1996 Sep; 165(3):216-26. PubMed ID: 8924680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1 reactivity as an imaging biomarker in myocardial tissue characterization discriminating normal, ischemic and infarcted myocardium.
    van Assen M; van Dijk R; Kuijpers D; Vliegenthart R; Oudkerk M
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1319-1325. PubMed ID: 31093894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free-breathing high-spatial-resolution delayed contrast-enhanced three-dimensional viability MR imaging of the myocardium at 3.0 T: a feasibility study.
    Amano Y; Matsumura Y; Kumita S
    J Magn Reson Imaging; 2008 Dec; 28(6):1361-7. PubMed ID: 19025943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac magnetic resonance evaluation of myocardial viability and ischemia.
    Strzelczyk J; Attili A
    Semin Roentgenol; 2008 Jul; 43(3):193-203. PubMed ID: 18486681
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial viability: assessment with three-dimensional MR imaging in pigs and patients.
    Dewey M; Laule M; Taupitz M; Kaufels N; Hamm B; Kivelitz D
    Radiology; 2006 Jun; 239(3):703-9. PubMed ID: 16641341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed contrast enhancement on MR images of myocardium: past, present, future.
    Ordovas KG; Higgins CB
    Radiology; 2011 Nov; 261(2):358-74. PubMed ID: 22012903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT imaging of myocardial viability: experimental and clinical evidence.
    Mahnken AH; Mühlenbruch G; Günther RW; Wildberger JE
    Cardiovasc J Afr; 2007; 18(3):169-74. PubMed ID: 17612749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New concepts in characterization of ischemically injured myocardium by MRI.
    Saeed M
    Exp Biol Med (Maywood); 2001 May; 226(5):367-76. PubMed ID: 11393166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury.
    Croisille P; Kim HW; Kim RJ
    Radiology; 2012 Oct; 265(1):12-22. PubMed ID: 22993217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of t2-weighted magnetic resonance imaging early after myocardial infarction in dogs: comparison with bis-gadolinium-mesoporphyrin enhanced T1-weighted magnetic resonance imaging and functional data from cine magnetic resonance imaging.
    Dymarkowski S; Ni Y; Miao Y; Bogaert J; Rademakers F; Bosmans H; Marchal G
    Invest Radiol; 2002 Feb; 37(2):77-85. PubMed ID: 11799331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast-enhanced MR and MSCT for the assessment of myocardial viability].
    Mahnken AH; Günther RW; Krombach G
    Rofo; 2006 Aug; 178(8):771-80. PubMed ID: 16862503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in ischemic heart disease.
    Steffans JC; Sakuma H; Bourne MW; Higgins CB
    Am Heart J; 1996 Jul; 132(1 Pt 1):156-73. PubMed ID: 8701859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
    Kwong RY; Korlakunta H
    Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late gadolinium enhancement imaging in assessment of myocardial viability: techniques and clinical applications.
    Jimenez Juan L; Crean AM; Wintersperger BJ
    Radiol Clin North Am; 2015 Mar; 53(2):397-411. PubMed ID: 25727002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
    Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
    AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.